Trypanosoma cruzi trypanosomiasis

Gutteridge, W.E., B. Cover, and A.J.D. Cooke. 1974. Safety precautions for work with Trypanosoma cruzi (Trypanosomiasis seminar). Trans. Royal Soc. Trop. Med. Hyg. 68 161. 

African trypanosomiasis (sleeping sickness) and American trypanosomiasis (Chagas disease) are caused by Trypanosoma brucei and Trypanosoma cruzi, respectively. Sleeping sickness results from being bitten by the insect vector, the tsetse fly. At first there is only local lymphadenitis but about a month later generalized malaise, fever, and systemic disease involving skeletal muscle is seen. 

Bfx and Fx derivatives have been evaluated against the parasites Trypanosoma cruzi (T. cruzi), which is responsible for American Trypanosomiasis and Plasmodium falciparum (P. falciparum) responsible for Malaria. 

Chagas disease, the South American variety of trypanosomiasis, is caused by Trypanosoma cruzi. It is quite different from African trypanosomiasis in its clinical and pathological presentation and in its failure to respond to many agents effective in that disease. It has both an acute and chronic phase. The latter frequently results in gastrointestinal and myocardial disease that ends in death. 

American trypanosomiasis or Chagas disease, named after Carlos Chagas, who first described it in 1909, exists primarily only on the American Continent. It is caused by Trypanosoma cruzi, a flagellate protozoan parasite. Chagas disease represents the leading cause of cardiac lesions in young, economically productive adults in the endemic countries in Latin America (Moncayo and Silveira, 2009). 

American trypanosomiasis (Chaga s disease) Trypanosoma cruzi Nifurtimox, benznidazole... 

The Chagas disease (American trypanosomiasis), caused by the protozoan Trypanosoma cruzi, is endemic to most regions of the Latin Americas. Of the estimated 18 million infected people, approximately 50,000 die from this disease yearly. Transfusion of blood from infected donors has become a major route for contracting the disease. The estimated seroprevalence of the disease in blood donor populations of the United Stated is as high as 0.48% and the trend is increasing with the Hispanic population. Concerns on the safety of blood in the U.S. have been raised because they represent a growing donor population but also a largely silent reservoir of T. cruzi. 

American trypanosomiasis, or Chagas disease, is caused by Trypanosoma cruzi. It affects -20 million people from Mexico to South America, where the chronic form of the disease is a major cause of cardiomyopathy, megaesophagus, megacolon, and death. Bloodsucking triatomid bugs most commonly transmit this infection to young children transplacental transmission also may occur in endemic areas. 

Preliminary evidence suggest that piquerol A (26a) can be a potential resource in the control of Chagas disease (American trypanosomiasis), an endemic illness which afflicts millions of people in Latin America [116]. The causal agent is the protozoan Trypanosoma cruzi, which is transmitted by insect vectors. 

HPPR-MP can compete favorably with the normal substrate. The enzym-ological data are consistent with the metabolic studies which show that a large concentration of HPPR-MP (1-2 mM) is found within the cell APPR-MP is formed very slowly and in concentrations about one-tenth that of its precursor. The rate-limiting step is the formation of succino-APPR-MP by the adenylosuccinate synthetase. This conversion does not occur in mammalian tissues. The same metabolic sequences have been shown to exist in the intracellular parasitic form of L. donovani, in the vitro culture form, the blood stream and intracellular forms of Trypanosoma cruzi >7 the causative agent of American trypanosomiasis, and in the African trypanosomes T. brucei and rhodesiense. ... 

Trypanosoma cruzi T. cruzi) The species of Trypanosoma responsible for Chagas disease or American trypanosomiasis. 

Antileishmanial activity of pannarine (66), I -chloropannarine (67), and (+)-usnic acid (50) against promastigote forms of Leishmania species was reported by Four-net and coworkers [83]. Weak trypanocidal activity of triterpenes 68-70 and dep-sides 71 and 72, isolated from Pseudocyphellaria corrifolia (Mull. Arg.) Malme, has been reported by Fritis and coworkers against Trypanosoma cruzi [84], Trypanosomiasis is a common vector-borne disease in tropical regions of the world. Successful remedies of the disease are much sought for (Table 2). 

Suramin is used primarily to treat African trypanosomiasis, for which it is the drug of choice. It is effective in treating disease caused by Trypanosoma gam-biense and T. rhodesiense but not T. cruzi (Chagas ... 

Trypanosomiasis is produced by protozoa of the genus Trypanosoma and leads to Gambian or mid-African sleeping sickness (T. gambiense), Rhodesian or East African sleeping sickness (T. rhodesiense), and Chagas disease, which is seen in the populations of Central and South America (T. cruzi). 

---